| Type 2 Diabetes Mellitus |
1 |
1 |
| Patient Safety |
0 |
0.99 |
| Adverse Effects |
0 |
0.55 |
| Multidisciplinary Team |
0 |
0.44 |
| Obesity |
0 |
0.43 |
| Adherence |
0 |
0.4 |
| Chronic Disease |
0 |
0.22 |
| Drug Shortage |
0 |
0.22 |
| Endocrinology |
0 |
0.22 |
| Hypoglycemia |
0 |
0.22 |
| Primary Care |
0 |
0.22 |
| Thyroid Disease |
0 |
0.21 |
| Thyroid Nodule |
0 |
0.19 |
| Continuous Glucose Monitoring |
0 |
0.12 |
| Healthcare and Medical Technology |
0 |
0.12 |
| Retinal Diseases |
0 |
0.12 |
| Revenue and Practice Management |
0 |
0.12 |
| Type 1 Diabetes Mellitus |
0 |
0.12 |
| Weight Management |
0 |
0.12 |
| Blood |
0 |
0.11 |
| Clinical Guidelines |
0 |
0.11 |
| Face |
0 |
0.11 |
| Gastroparesis |
0 |
0.11 |
| Insulin Pump |
0 |
0.11 |
| Medical Innovations |
0 |
0.11 |
| Nodule |
0 |
0.11 |
| Noninsulin Antidiabetic Drugs |
0 |
0.11 |
| Other Specialty |
0 |
0.11 |
| Receptors |
0 |
0.11 |
| Referral |
0 |
0.11 |
| Retinopathy |
0 |
0.11 |
| Salary and Compensation |
0 |
0.11 |
| Sulfonylureas |
0 |
0.11 |
| Thyroid |
0 |
0.11 |
| Weight Loss |
0 |
0.11 |